Commonly used antibiotic shows promise for combating Zika infections
NIH preclinical study suggests FDA-approved tetracycline-based antibiotics may slow infection and reduce neurological problems.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Brain | National Institutes of Health (NIH) | Neurology | Study | Tetracycline | Zika Virus